Antibiotics changed the shape of modern medicine, and among those, ampicillin stands as a landmark. In the early 1960s, British researchers at Beecham Laboratories gave the world this β-lactam antibiotic, offering a broader spectrum than earlier penicillins. The discovery opened doors for treating both gram-positive and gram-negative infections, helping clinicians battle troublesome bugs like Salmonella, Shigella, and Escherichia coli. Doctors around the globe quickly adopted ampicillin, especially in regions struggling with resistant strains, as part of the arsenal that pulled countless lives back from the edge. Soon after, pharmaceutical companies scaled up production and governments included it in essential medication lists, making it a household name for parents, travelers, and hospital workers alike.
Ampicillin comes as a white crystalline powder, usually packed in moisture-resistant vials or capsules. You find it in sodium salt forms for IV and IM use, or as oral capsules. Pharmacy shelves carry it in standard doses, most commonly 250 mg and 500 mg for oral use, while injectable forms vary based on hospital protocols. It's a core choice for treating respiratory, urinary, gastrointestinal, and even neonatal infections. Children get it in syrup form, reducing the struggle for pediatric dosing. Hospitals keep it on hand for quick deployment in cases of suspected sepsis or meningitis, pushing its role beyond the outpatient setting and marking its place in frontline emergency care.
Ampicillin exhibits a molecular formula of C16H19N3O4S and a molecular weight of 349.4 g/mol. The powder doesn’t dissolve well in water unless prepared as its sodium salt, so manufacturers adjust forms based on the method of administration. It holds a melting point between 200–205 °C, resisting breakdown up to relatively high temperatures, which improves shelf life. The β-lactam ring within its core structure brings the bacteria-fighting punch, but the same chemical prowess leads to potential instability if left in warm or humid conditions too long. Pharmacies recommend cool, airtight storage to keep it potent.
Manufacturers label ampicillin products with batch numbers, expiry dates, and usage instructions that meet strict pharmacopeial guidelines. Data sheets spell out maximum impurity limits, expected potency ranges—usually 90–110% of the stated amount—and detailed reconstitution guides for injectables. For liquid suspensions, colorimeters check clarity and absence of particulate matter. Every lot arrives with quality assurance paperwork to satisfy regulatory bodies in every major country. Dosage instructions focus on weight, age, and diagnosis, which minimizes the risk of side effects. Hospitals rely on barcode tracking of every vial, tying modern logistics tightly to patient safety.
The manufacturing journey starts with 6-aminopenicillanic acid (6-APA), the backbone of many penicillins. Chemical reactions with D-phenylglycine derivatives, under controlled conditions, produce ampicillin through enzymatic or chemical amidation. After purification, manufacturers standardize the product through recrystallization. Quality control teams test every batch for purity, sterility, and microbial contamination, ensuring that the final drug matches strict regulatory standards. The technology for producing ampicillin has hardly changed in the last few decades, largely because it remains so effective in producing high yields without much waste. Any deviation in temperature, pH, or timing can ruin a batch, so plants rely on automated monitors, technician oversight, and round-the-clock checks.
Chemists have explored ways to modify ampicillin to overcome bacterial resistance and expand its usefulness. The β-lactam ring opens up opportunities for structural tweaks, but even small changes can alter activity drastically. Adding protective groups guards the molecule from destructing enzymes like β-lactamases, but some bacteria can still break it down. Laboratories experiment with side-chain additions, hoping to boost stability or improve absorption. A few derivatives like bacampicillin, designed for better oral bioavailability, have reached the market, but most tweaks have not surpassed the original ampicillin’s reach. It’s a classic—a workhorse molecule that has outlasted many newer competitors through sheer reliability.
Ampicillin tends to pop up under many names, depending on its form and manufacturer. Some know it as Penbritin, Totacillin, or Principen. Search through hospital inventories or global supply chains, and the names keep multiplying—Ampi, Omnipen, Standacillin, and more. Generic labeling ensures worldwide recognition, though differences in excipients and packaging can mean slight changes in appearance or shelf life. Any pharmacy worker or nurse with years on the floor recalls at least three or four common trade names, their differences burned in through years of dosing and reconstitution.
Handling ampicillin in any setting calls for a focus on hygiene, traceability, and allergic reaction risk. Allergic responses, particularly for people with penicillin allergies, can escalate quickly; anaphylaxis is rare but real, so medical staff always keep epinephrine nearby when giving IV doses. Manufacturing plants run regular audits to keep cross-contamination at bay. Hospitals embed ampicillin into electronic record systems, allowing caregivers to double-check allergies, dose adjustments, and interaction warnings in real time. Staff receive routine training in sterile technique for injectables and hand hygiene, treats such as ampicillin as both a cure and a responsibility. In my years working side by side with nurses, watching for penicillin allergies has saved more than one patient from a dangerous outcome.
Doctors count on ampicillin for a long list of infections, from throat and ear problems in kids to life-threatening meningitis in neonates. It reaches into both rural clinics and major teaching hospitals, treating everything from food poisoning to bacterial endocarditis. Veterinarians use it for animal infections, backing up its reputation in both human and animal medicine. Surgeries often see a pre-op ampicillin shot warding off dangerous bacteria—especially in high-risk procedures or immunocompromised patients. Overuse sparks resistance concerns, so stewardship teams track every prescription, balancing immediate need against the fight to keep antibiotics working tomorrow.
Labs around the world examine ampicillin’s molecular structure in their quest for next-generation antibiotics. Some push to combine it with β-lactamase inhibitors like sulbactam or clavulanic acid, searching for synergies that outflank resistant bacteria. Others focus on delivery formats—nanoformulations, slow-release injectables, or inhalable powders—for better patient outcomes. Scientists track patterns in microbial susceptibility, writing papers that help guide front-line protocols and nudge pharmaceutical pipelines. The ongoing COVID-19 crisis underscored the importance of trusted, established antibiotics in handling secondary infections, breathing new life into the study of drugs like ampicillin even as labs race for new cures.
Every medication walks a line between benefit and harm, and ampicillin’s safety record counts as one of medicine’s stronger bets. Animal studies set early toxicity limits, guiding dose recommendations in humans. Some patients still face side effects—rashes, digestive problems, or, rarely, severe immune reactions. Over years, pharmacovigilance teams clock reports and adjust guidelines to reduce risk. Environmental concerns come up with antibiotic run-off into waterways, nudging research groups to study ecological toxicity and propose cleanup measures. In my time shadowing infectious disease experts, the message comes clear: The right dose heals, the wrong dose harms, and both patient and planet demand careful stewardship from every administrative step.
The world’s armory against infection keeps changing as new resistant strains pop up across the globe, pressing researchers to re-examine legacy molecules like ampicillin. Some see promise in pairing it with new enzyme blockers or designing hybrid drugs that borrow ampicillin’s broad spectrum and plug resistance gaps. Upgrades in synthesis aim to cut production waste or use renewable resources, a nod to environmental priorities. Clinicians, researchers, and regulatory leaders meet in regular conferences, focusing on balancing dependable old antibiotics with breakthrough treatments. Keeping ampicillin effective means sticking close to stewardship programs, investment in research, and spreading education on smart global use. Patients may never know the chemistry or politics behind their pill or shot, but every dose draws from deep wells of history, care, and evolving science.
Ampicillin stands out in the long list of antibiotics. It fights bacteria and does this job by disrupting how bacteria build their cell walls. Without the strength of a good wall, bacteria can't survive in a world full of threats, including our immune systems. Family doctors and hospital specialists count on ampicillin to treat infections caused by specific bacteria. It isn’t some catchall medicine for every sniffle, though. Ampicillin has shown strong results against respiratory infections like pneumonia, infections of the ear, urinary tract infections, and even more serious problems like meningitis caused by certain bacteria.
People reach for antibiotics expecting a quick fix, but not all antibiotics treat the same infections. Ampicillin made its name before I was born, but it still gets used today, especially when other choices fall short or when lab tests show the infecting bacteria will respond. I once spent time helping in a community clinic, and I saw plenty of urgent cases: young kids with high fevers, older adults with painful urination, college students with sore throats. For many, the standard run-of-the-mill antibiotic just didn’t help. It was the broad reach of ampicillin that allowed doctors to save lives, particularly when fighting off things like bacterial meningitis, which moves fast and can kill if the right treatment isn’t started quickly.
Ampicillin comes from the penicillin family, but it can tackle some bacteria that penicillin can’t handle. Its spectrum is wider because it handles both Gram-negative and Gram-positive bacteria. Most “regular” penicillins mainly treat Gram-positive bugs. This is why labs test bacteria from an infection to check which medicine works best. I’ve met folks who thought antibiotics are all the same, but using the wrong one can actually make things worse by letting bacteria grow stronger. Ampicillin offers an option for those stubborn infections other penicillins can’t touch.
No story about antibiotics deserves to skip the issue of resistance. Misusing ampicillin, like skipping doses or using it for colds and flus (which viruses cause), only helps bacteria learn new tricks. In hospitals, resistant bacteria force doctors to switch to stronger, more toxic drugs. Researchers are tracking which infections still respond to this medicine, and pharmacists spend time teaching patients how important it is to finish the full course. One answer is better education, both for doctors and patients, about using antibiotics properly. Quick lab testing can make sure each patient receives the right medicine, not just the most popular or convenient one.
In many developing communities, ampicillin continues to save lives thanks to its low cost and track record. It’s available in pills, liquid, and even as an injection for serious infections. It travels to remote clinics because it doesn’t spoil easily, and doctors in rural hospitals trust it. Yet, as bacteria change, the world can’t rely on it forever. Public health programs need to preserve its power by promoting vaccination, clean water, and infection control measures—fewer infections mean fewer chances for resistance to develop.
Ampicillin shows up with regularity on prescription pads, especially for people dealing with bacterial infections. It has been part of the health toolkit for decades. For many people, this medicine clears up chest, bladder, or sinus infections. Along with the good Ampicillin can do, it also brings some baggage in the form of side effects. Knowing what can happen gives folks control and confidence during their treatment.
Ampicillin can upset stomachs. Nausea, bloating, and mild abdominal pain set in for some folks. Diarrhea comes up as another regular complaint. Research from the U.S. National Library of Medicine reports that digestive concerns affect up to 10-20% of users. Whether it’s sudden toilet runs or mild queasiness, digestive woes disrupt daily routines, sometimes leading people to skip doses or abandon their medication. Those lapses can push infections to linger or get worse.
Allergic reactions to Ampicillin deserve real concern. Skin rashes seem to crop up more often in kids, especially when treating viral illnesses that got mistaken for bacterial ones. The classic red, blotchy rash alarms parents and patients alike. In rare instances, reactions turn serious with swelling, difficulty breathing, or hives—signs of a medical emergency. Studies show allergy risk sits between 1% and 10%, which might seem small, but if you’re the one affected, that number feels huge.
From my own experience, sitting in waiting rooms has taught me that people worry about every new symptom. It’s not just the infection; it’s the medication too. As Ampicillin courses through the body, it doesn’t always know friend from foe. It can wipe out helpful gut bacteria, leading to yeast infections, particularly in women. The CDC warns about the link between antibiotics and fungal overgrowth, which triggers itching and discharge that no one finds comfortable.
Headaches and dizziness also pop up, though not as often. For people juggling jobs or family responsibilities, even mild headaches can sap focus. Short-term antibiotics sometimes push the body hard, and the side effects stack up with stress and poor sleep.
Recognizing new symptoms early on can make a difference. Clear information empowers people to track symptoms and speak up if something feels off. Pharmacists have become a resource for families, explaining what signs to watch out for and when to call a doctor.
People with kidney issues or allergies to penicillin have greater risks than the average person. Tailored prescriptions make all the difference here. Medical guidelines recommend that those with previous drug allergies steer clear or receive close monitoring.
Doctors now encourage patients to finish their full course of Ampicillin, even if symptoms improve partway through. Stopping early can foster resistant bacteria and not fully clear infection. Staying hydrated, eating regular meals, and taking probiotics with approval from healthcare providers may help keep side effects in check. If symptoms make daily life tough or seem to get worse, a return visit to the clinic makes sense.
Open conversations with honest questions go a long way toward safe, stress-free treatment. Experience in family medicine has shown that most people can handle Ampicillin with some preparation, but those little side effects left unchecked create big discomfort. Understanding what to expect arms everyone with peace of mind to focus on getting better.
Life doesn’t pause when an infection hits. Those on the edge of their seats dealing with sore throats, fever, or even something more complex like a urinary tract infection often hear “Ampicillin” from their doctor. This antibiotic carries serious weight in medical care. Missteps in how it’s taken can decide between bouncing back quickly or letting an infection linger, sometimes leading to bigger health risks.
Ampicillin usually shows up as either capsules, tablets, or a liquid suspension. It also gets administered as an injection or IV in hospitals. Food and timing really matter here. From long conversations with pharmacists and a few late-night Google searches, there’s one bit of advice repeated by every expert: Take Ampicillin on an empty stomach — an hour before or two hours after eating. This one small shift actually helps your body absorb the medicine more effectively, giving it the best chance to wipe out bacteria.
Swallowing pills with a full glass of water avoids stomach upset. The liquid form often comes with its own measuring device: use that for accuracy. No good comes from guessing at doses, especially with antibiotics. Anyone who has helped a stubborn toddler finish a course of antibiotics knows just how important it is not to stop halfway when symptoms disappear. Leftover bacteria can flare up again, this time even harder to treat.
Many folks believe they can stop antibiotics when they “feel better.” That move increases the risk of antibiotic resistance, a problem affecting thousands across the globe. The Centers for Disease Control and Prevention warns that incomplete courses breed “superbugs” unbothered by antibiotics, making future infections harder and more expensive to treat. Prescribers don’t randomize these instructions; there’s a real plan behind that prescription label.
Every infectious disease doctor seems to share stories about patients whose infections came back nastier just because they ran out of patience. Taking every scheduled dose — not missing doses, not doubling up if one’s missed — forms a simple routine with big rewards. Setting reminders helps when life gets hectic. In hospitals, nurses keep perfect schedules with IVs or injections, so infections stand little chance.
Upset stomach, mild diarrhea, or a rash can pop up during treatment. Many side effects settle on their own, but severe allergic reactions deserve immediate medical attention. Anyone with a known allergy to penicillin should speak up before starting treatment. Even the smallest detail in your health history can change the doctor’s approach, which might mean a different, safer antibiotic.
Pharmacists, doctors, and even apps play a big part in helping patients stick to antibiotic instructions. I’ve seen families put sticky notes on the fridge or use pill organizers to avoid mistakes. Better education on the dangers of skipping doses would curb antibiotic resistance. Regular follow-ups with healthcare professionals—especially when a person doesn’t improve—will catch issues before they spiral.
Antibiotics like Ampicillin aren’t magic; they’re a partnership between medicine and the patient’s daily habits. Small steps—right timing, finishing the prescribed course, honest conversations with health providers—help protect this life-saving tool for future generations.
Pregnancy changes a lot about a person’s daily choices, especially the ones tied to health. Medicines that helped before suddenly spark new questions. Ampicillin, an antibiotic doctors have prescribed for decades, often comes up in conversations between soon-to-be parents and their care teams. The stakes feel high, since any medicine can raise concerns for expecting or nursing families. I remember that nervousness myself—trusting a doctor, but also wanting more than a quick yes or no.
Some infections get risky fast during pregnancy—urinary tract infections, group B strep, and more. Doctors often turn to tried-and-true antibiotics, and ampicillin has a long track record in medical settings. The science says it crosses the placenta. This fact means people with questions deserve clear answers. The U.S. Food and Drug Administration places ampicillin in Pregnancy Category B. Studies on animals haven’t shown birth defects, even at doses higher than usually recommended for humans. Decades of use in pregnant patients have not turned up clear evidence of birth defects or problems, but every decision weighs individual risks and benefits.
No one wants to gamble with their baby’s health, and the truth is, all medicines deserve scrutiny in these chapters of life. Doctors tend to choose the least risky, most proven options. Based on the best research, ampicillin stands out as one of those choices if an infection needs antibiotics. Some side effects—like allergic reactions, rashes, or stomach upset—still need discussion. It helps to talk openly, not just about the science, but about fears, experiences, and options. No study replaces a conversation of trust with a primary care provider or obstetrician. People who have had allergic reactions to any penicillins or cephalosporins should always alert their doctor first.
New parents also want to know about breastfeeding. Ampicillin passes into breast milk, but only in small amounts. The American Academy of Pediatrics calls it compatible with breastfeeding because problems show up very rarely. If a baby has unusual fussiness, rash, or diarrhea, it’s worth asking if the medicine plays a role. In my own family, support from a healthcare team during these visits made it easier to weigh benefits—like clearing up an infection fast—against side effects that were nearly always mild or brief. Not every medicine can boast a safety record like this during breastfeeding, so I know why parents feel some relief knowing ampicillin often stays on the approved list.
Pregnancy and breastfeeding both stretch patience and sharpen instincts. All antibiotics come with some tradeoffs, and this one holds up well in scientific reviews and real-world use. That doesn’t mean skipping the conversation about personal medical history or allergies. It means remembering that treating bacterial infections quickly often prevents bigger problems for parent and baby. Most questions boil down to talking honestly with a healthcare provider who keeps up with the latest updates and who listens.
Guidelines continue to shape how ampicillin fits into treatment plans, but medicine isn’t just about charts. It’s heart, trust, and up-to-date science brought together. Families who ask these questions push everyone in healthcare to do better. People checking on safety, seeking out simple answers, and relying on evidence make for healthier outcomes. If you have upcoming appointments or new prescriptions, keep asking. If you face new symptoms, reach out early. Ampicillin remains an option for many, but the best decision always comes with real advice in real time from someone you trust.
Life can get complicated for people taking ampicillin. This antibiotic fights bacterial infections, but antibiotics never work alone in the body. Everything a person eats or any extra drugs they pick up along the way can change how well ampicillin does its job. Without proper care, some combinations water down the benefits or even trigger side effects. I always tell friends who get a new prescription: pay close attention not just to what you swallow, but what you’re already taking or planning to eat tonight.
Allergies, aches, and stomach bugs often mean a loaded medicine cabinet. Yet, a few drugs make ampicillin work less effectively, or stir up problems. Allopurinol, widely used for gout, raises the chance of skin rashes. Mixing methotrexate and ampicillin creates bigger trouble, pushing methotrexate into the blood and straining the kidneys. Probenecid—often prescribed to slow elimination of antibiotics—also keeps ampicillin around longer, but that’s not always helpful. The ampicillin levels can rise too much, irritating the stomach or causing side effects. Relying on birth control pills? Ampicillin may weaken oral contraceptives, opening the door for surprise pregnancies. Doctors usually warn about this, but sometimes people only find out the hard way.
Food affects how much ampicillin the gut absorbs. Meals with heavy fat or lots of protein slow down the antibiotic getting into the bloodstream. I’ve watched folks grab their antibiotic with breakfast, thinking it’ll protect their stomach. Instead, the infection can stick around longer. The old-school advice still rings true: take ampicillin on an empty stomach with a glass of water, about an hour before eating or two hours afterward. Dairy counts, too. Milk, cheese, and yogurt make the medicine less effective, and the bacteria get a stronger foothold. Combining ampicillin with acidic fruit juices doesn’t help, either—these juices change the way the gut handles the drug.
Friends often ask if a drink really mixes badly with antibiotics. For ampicillin, alcohol doesn’t block the drug, but both can upset the stomach or cause loose stools. Juggling a new prescription with a busy social life means paying attention to what your body is telling you, and taking it easy if nausea or diarrhea crop up.
I tell anyone starting new medicine to write down every pill, vitamin, and herbal supplement they use, no matter how minor it may seem. Doctors and pharmacists are trained to spot trouble, but they need the facts laid out. Read prescription labels carefully for warnings, and never hesitate to call a pharmacy or a local nurse with a fast question. A quick chat now prevents bigger issues later. Be skeptical about internet lists—ampicillin may seem ordinary, but only a qualified person can give you the details that fit your life and your health history.
Mixing ampicillin with the wrong drug or meal isn’t just a minor oops; it can keep people sick longer or deliver a genuine health scare. Learning about food and drug interactions keeps infections from dragging on and helps folks bounce back faster. Everyone deserves to feel confident and supported as they heal.
| Names | |
| Preferred IUPAC name | (2S,5R,6R)-6-[(2R)-2-Amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid |
| Other names |
Aminobenzylpenicillin Penbritin Polycillin Principen |
| Pronunciation | /ˌæm.pɪˈsɪl.ɪn/ |
| Preferred IUPAC name | (2S,5R,6R)-6-[(2R)-2-amino-2-phenylacetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid |
| Other names |
Aminobenzylpenicillin Penbritin Principen |
| Pronunciation | /ˌæm.pɪˈsɪl.ɪn/ |
| Identifiers | |
| CAS Number | 69-53-4 |
| Beilstein Reference | 3494349 |
| ChEBI | CHEBI:28971 |
| ChEMBL | CHEMBL25 |
| ChemSpider | 5288907 |
| DrugBank | DB00415 |
| ECHA InfoCard | 03e9d2d1-250b-44f9-b1e1-8bdb47c7dbf2 |
| EC Number | 3.5.2.6 |
| Gmelin Reference | 5899 |
| KEGG | D00208 |
| MeSH | D000900 |
| PubChem CID | 6249 |
| RTECS number | XH7450000 |
| UNII | 7KQ279618W |
| UN number | UN2811 |
| CompTox Dashboard (EPA) | DTXSID2022946 |
| CAS Number | 69-53-4 |
| Beilstein Reference | 1711048 |
| ChEBI | CHEBI:28971 |
| ChEMBL | CHEMBL (CHEMBL785) |
| ChemSpider | 222 |
| DrugBank | DB00415 |
| ECHA InfoCard | 100.003.283 |
| EC Number | 3.5.2.6 |
| Gmelin Reference | 62294 |
| KEGG | C00321 |
| MeSH | D000900 |
| PubChem CID | 6249 |
| RTECS number | XH2685000 |
| UNII | 7C5697Y6YS |
| UN number | UN2811 |
| CompTox Dashboard (EPA) | DTXSID7020265 |
| Properties | |
| Chemical formula | C16H19N3O4S |
| Molar mass | 349.4 g/mol |
| Appearance | White or almost white crystalline powder |
| Odor | Odorless |
| Density | 0.72 g/cm3 |
| Solubility in water | Sparingly soluble |
| log P | -1.35 |
| Acidity (pKa) | 2.5 |
| Basicity (pKb) | 2.55 |
| Refractive index (nD) | 1.7 |
| Dipole moment | 1.35 D |
| Chemical formula | C16H19N3O4S |
| Molar mass | 349.4 g/mol |
| Appearance | A white to off-white crystalline powder |
| Odor | Odorless |
| Density | 1.444 g/cm³ |
| Solubility in water | Slightly soluble |
| log P | -1.35 |
| Acidity (pKa) | 2.5 |
| Basicity (pKb) | 2.5 |
| Dipole moment | 2.23 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 218 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -389.7 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -3225 kJ/mol |
| Std molar entropy (S⦵298) | 322.8 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -389.7 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -3346 kJ/mol |
| Pharmacology | |
| ATC code | J01CA01 |
| ATC code | J01CA01 |
| Hazards | |
| Main hazards | May cause allergic reactions; potential for serious hypersensitivity (anaphylactic) reactions; gastrointestinal disturbances; risk of superinfection with prolonged use. |
| GHS labelling | GHS05, GHS07 |
| Pictograms | pill, injection, prescription |
| Signal word | Warning |
| Hazard statements | Hazard statements: Causes eye irritation. May cause respiratory irritation. |
| Precautionary statements | Store at controlled room temperature (20° to 25°C [68° to 77°F]); protect from light; keep out of reach of children; use only if solution is clear and free from particulate matter; discard unused portion. |
| NFPA 704 (fire diamond) | Health: 2, Flammability: 0, Instability: 0, Special: -- |
| Lethal dose or concentration | LD₅₀ (oral, rat): 17,000 mg/kg |
| LD50 (median dose) | LD50 (median dose): 7,000 mg/kg (oral, mouse) |
| NIOSH | AS0112000 |
| PEL (Permissible) | PEL (Permissible) of Ampicillin: Not established |
| REL (Recommended) | 1-2 g every 4-6 hours |
| IDLH (Immediate danger) | No IDLH established. |
| Main hazards | May cause allergic reactions, including anaphylaxis; gastrointestinal disturbances; rash; potential for superinfection; use with caution in patients with penicillin allergies. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | Anti-infectives, Prescription only, Hospital-use, Oral, Injectable |
| Signal word | Warning |
| Hazard statements | Hazard statements: May cause an allergic skin reaction. May cause allergy or asthma symptoms or breathing difficulties if inhaled. |
| Precautionary statements | P264, P270, P273, P280, P301+P312, P305+P351+P338, P308+P313, P501 |
| Lethal dose or concentration | LD₅₀ (oral, mouse): 7000 mg/kg |
| LD50 (median dose) | LD50 (median dose) of Ampicillin: "3500 mg/kg (oral, mouse) |
| NIOSH | YX6S3P12V6 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 250 mg every 6 hours |
| IDLH (Immediate danger) | The IDLH (Immediate Danger to Life or Health) for Ampicillin is: "Not listed |
| Related compounds | |
| Related compounds |
Amoxicillin Bacampicillin Metampicillin Hetacillin Penicillin |
| Related compounds |
Amoxicillin Penicillin Methicillin Oxacillin Cloxacillin Dicloxacillin |